DBV Technologies | DBVT

Aktienkurs
20.59
Täglich Wechseln
-0.81 -3.79%
Monatlich
-0.58%
Jährlich
181.28%
Q2 Prognose
20.10



Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 21.74 -0.83 -3.68% 49.11% 2026-04-10
Alnylam Pharmaceuticals 322.11 0.83 0.26% 35.47% 2026-04-10
Amarin 14.48 -0.30 -2.03% 55.70% 2026-04-10
BioCryst Pharmaceuticals 9.56 -0.33 -3.34% 40.18% 2026-04-10
BioMarin Pharmaceutical 54.53 -1.77 -3.14% -4.03% 2026-04-10
DBV Technologies 20.59 -0.81 -3.79% 181.28% 2026-04-10
Esperion Therapeutics 2.17 -0.01 -0.46% 112.75% 2026-04-10
Galectin Therapeutics 2.30 -0.13 -5.35% 70.37% 2026-04-10
Halozyme Therapeutics 67.82 0.74 1.10% 12.62% 2026-04-10
Incyte 96.07 -0.89 -0.92% 68.93% 2026-04-10

Preis Tag Jahr Datum
USND 22903 80.48 0.35% 36.94% 2026-04-10